Alzamend NeuroALZN
13F holders, Q4 2025 (December 31)13holders +2
3new positions
2sold out
$1.82avg. 13F price*
At the end of Q4 2025, 13 institutions reported holding Alzamend Neuro Inc. (ALZN) in their 13F filings, up 2 from Q3 2025. 3 opened new positions and 2 sold out. The largest holders were DRW Securities, LLC ($212K), Geode Capital Management, LLC ($50K) and UBS Group AG ($45K).
- Company
- Alzamend Neuro Inc.
- CUSIP
- 02262M605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $78K |
| Exits | 2 | $2 |
All 13F filers, Q3 2025 → Q4 2025: 98,027 shares bought and 1 shares sold, net +98,026 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| DRW Securities, LLC | 0.02% | Add +27.5% | 116,319 | $212K |
| Geode Capital Management, LLC | 0.00% | Add +33.7% | 27,506 | $50K |
| UBS Group AG | 0.00% | Add +1084.0% | 24,567 | $45K |
| Vanguard Group Inc. | 0.00% | No change | 21,620 | $39K |
| Morgan Stanley | 0.00% | New | 18,000 | $33K |
| Virtu Financial LLC | 0.00% | New | 12,582 | $23K |
| XTX Topco Ltd | 0.00% | New | 12,470 | $23K |
| Clearstead Advisors, LLC | 0.00% | No change | 10,000 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +29.6% | 2,081 | $4K |
| BlackRock, Inc. | 0.00% | No change | 437 | $795 |
| Bank of America Corp. | 0.00% | Add +16.2% | 43 | $78 |
| SBI Securities Co., Ltd. | 0.00% | No change | 22 | $40 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is ALZN's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.